Cargando…

Correction: Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639141/ https://www.ncbi.nlm.nih.gov/pubmed/36332940 http://dx.doi.org/10.1136/rmdopen-2022-002216corr1

Ejemplares similares

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
por: Krieckaert, Charlotte, et al.
Publicado: (2022)

Value of imaging to guide interventional procedures in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Bosch, Philipp, et al.
Publicado: (2021)

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Burska, Agata, et al.
Publicado: (2023)

Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases
por: Marques, Andréa, et al.
Publicado: (2022)

Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2023)

Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider
por: Ritschl, Valentin, et al.
Publicado: (2020)

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
por: Najm, Aurélie, et al.
Publicado: (2019)

Assessment of competences in rheumatology training: results of a systematic literature review to inform EULAR points to consider
por: Alunno, Alessia, et al.
Publicado: (2020)

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
por: Kostine, Marie, et al.
Publicado: (2021)

EULAR ‘points to consider’ for the conduction of workforce requirement studies in rheumatology
por: Dejaco, Christian, et al.
Publicado: (2018)

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

Eular Textbook on Rheumatic Diseases
por: Adwan, Marwan H.
Publicado: (2015)

Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider
por: Najm, Aurélie, et al.
Publicado: (2021)

Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
por: Alunno, Alessia, et al.
Publicado: (2021)

Recommendations for the content and conduct of European League Against Rheumatism (EULAR) musculoskeletal ultrasound courses
por: Naredo, E, et al.
Publicado: (2008)

Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups
por: Najm, Aurélie, et al.
Publicado: (2018)

Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
por: Santos, Eduardo José Ferreira, et al.
Publicado: (2023)

Correction: Development of generic core competences of health professionals in rheumatology: a systematic literature review informing the 2018 EULAR recommendations
Publicado: (2019)

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
por: Alunno, Alessia, et al.
Publicado: (2021)

Prevention and management of osteoporotic fractures by non-physician health professionals: a systematic literature review to inform EULAR points to consider
por: Wilson, Nicky, et al.
Publicado: (2020)

Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider
por: Alunno, Alessia, et al.
Publicado: (2021)

EULAR points to consider for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures
por: Studenic, Paul, et al.
Publicado: (2022)

Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider
por: Unger, Julia, et al.
Publicado: (2018)

Methodological aspects of design, analysis and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis: results of two systematic literature reviews informing EULAR points to consider
por: Marques, Mary Lucy, et al.
Publicado: (2021)

Person-focused care for young people with rheumatic and musculoskeletal diseases: young rheumatologists' and EULAR Young PARE perspectives
por: Alunno, Alessia, et al.
Publicado: (2017)

Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases
por: Dreesen, Erwin, et al.
Publicado: (2017)

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Gwinnutt, James M, et al.
Publicado: (2022)

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis
por: Boonen, Annelies, et al.
Publicado: (2021)

Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Wieczorek, Maud, et al.
Publicado: (2022)

Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals
por: Schulthess, Duane, et al.
Publicado: (2022)

Correction to: Characteristics of therapeutic alliance in musculoskeletal physiotherapy and occupational therapy practice: a scoping review of the literature
por: Babatunde, Folarin, et al.
Publicado: (2017)

Role of ultrasonography in the diagnosis of rheumatic diseases in light of ACR/EULAR guidelines
por: Płaza, Mateusz, et al.
Publicado: (2016)

Correction to: Evaluating the performance of ACR, SLICC and EULAR/ACR classification criteria in childhood onset systemic lupus erythematosus
por: Abdwani, Reem, et al.
Publicado: (2021)

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
por: Rondaan, Christien, et al.
Publicado: (2019)

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
por: Ghalandari, Nafise, et al.
Publicado: (2022)

Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology
por: Lauper, Kim, et al.
Publicado: (2021)

Correction: Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2q0gkn5pe7bs2t3bvfavh8bnq3